Search Results - "Grosshans, D.R"
-
1
Pediatric Radiation Oncology Practice Patterns: After Protons
Published in International journal of radiation oncology, biology, physics (01-11-2015)Get full text
Journal Article -
2
-
3
Clinical Outcomes of Pediatric Patients With Pelvic Tumors Treated With Proton Therapy
Published in International journal of radiation oncology, biology, physics (01-10-2016)Get full text
Journal Article -
4
Clinical Outcomes and Toxicity Following Proton Radiation Therapy for Head and Neck Rhabdomyosarcoma
Published in International journal of radiation oncology, biology, physics (01-10-2016)Get full text
Journal Article -
5
-
6
-
7
-
8
Clinical Outcomes of Children With Medulloblastoma After Proton Radiation Therapy
Published in International journal of radiation oncology, biology, physics (01-11-2015)Get full text
Journal Article -
9
-
10
Evolution of Proton Therapy and Advanced Radiation Techniques for Retinoblastoma
Published in International journal of radiation oncology, biology, physics (01-09-2014)Get full text
Journal Article -
11
-
12
-
13
-
14
Evaluation of Scanning Beam Proton Therapy for Medulloblastoma Boost Treatment
Published in International journal of radiation oncology, biology, physics (01-11-2012)Get full text
Journal Article -
15
Verification of Multi-field Optimized Proton Pencil Beam Treatment Plans
Published in International journal of radiation oncology, biology, physics (2011)Get full text
Journal Article -
16
-
17
Correlation of Pulmonary and Cardiac Dose–volume Histogram (DVH) Data with the Development of Radiation Adverse Events following Chemoradiation: Secondary Analysis of Radiation Therapy Oncology Group (RTOG) 0324
Published in International journal of radiation oncology, biology, physics (2009)Get full text
Journal Article -
18
ATRXLoss Increases Sensitivity to Proton Radiotherapy Compared to X-Ray Radiotherapy in Glioma Stem Cells via Secondary Necrosis
Published in International journal of radiation oncology, biology, physics (01-11-2021)“…Glioblastoma Multiforme (GBM-Grade IV) is the most aggressive form of glioma in the USA carrying only a 15 month median survival time. Although IDH1R132H is…”
Get full text
Journal Article -
19
-
20
Derivation of LET-Dependence of LQ Model Beta Parameter From a Microdosimetric Cell Survival Model
Published in International journal of radiation oncology, biology, physics (01-10-2017)Get full text
Journal Article